EGFR/HER2-IN-5
EGFR/HER2-IN-5 is an orally bioavailable, irreversible dual inhibitor of EGFR (IC50: 0.6 nM) and is effective against resistant mutations like L858R/T790M. It demonstrates significant in vivo antitumor efficacy, making it a valuable chemical tool for research in non-small cell lung cancer (NSCLC) and tyrosine kinase inhibitor resistance.
Product Specifications
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog